Aneurysm Coiling & Embolization Devices Market Overview
The Aneurysm Coiling & Embolization Devices Market was valued at USD 2.19 Billion in 2025 and is projected to reach USD 4.81 Billion by 2032, growing at a CAGR of 9.1% during 2026–2032, with North America holding the largest share.
Primary Drivers
- Rising global prevalence of cerebral aneurysms and cerebrovascular disorders, amplified by ageing populations and hypertension, is expanding the treated patient pool.
- Strong clinical shift from open surgical clipping toward minimally invasive endovascular coiling, driven by shorter recovery times and favourable outcome data.
- Continuous product innovation - bioactive and hydrogel coils, flow diverters, intrasaccular devices - plus improved neuroimaging and incidental detection rates are widening treatment eligibility.
Primary Challenges
- High device and procedure costs, plus limited reimbursement in emerging markets, restrict access to endovascular aneurysm treatment.
- A severe shortage of trained interventional neuroradiologists and neurosurgeons and the need for cath-lab/neuro-hybrid infrastructure limits procedure capacity.
- Clinical risks including coil compaction, aneurysm recanalisation and re-treatment rates, alongside stringent regulatory approval pathways and competition from flow diverters and clipping, constrain adoption.
This report includes a dedicated chapter covering supply chain exposure, export controls, sanctions risk, and regulatory shifts affecting Aneurysm Coiling & Embolization Devices Market.
Aneurysm Coiling & Embolization Devices Market Strategic Outlook
In Aneurysm Coiling & Embolization Devices, the endovascular coiling separates an aneurysm from getting entangled with the usual movement without blocking any small arteries close to the main vessel. The endovascular coiling proves to be a slightly offensive technique of opening the aneurysm from within the bloodstream, particularly during angiography. The Aneurysm Coiling & Embolization Devices are the ones in which the Embolization Device (PED) is specified for the endovascular action of adults (22 years of age or grown-ups) with giant wide-necked intracranial aneurysms (lAs) in the inner carotid vein from the petrous to the larger hypophyseal sections.
Growth trajectory, 2026–2032
How this market is covered
Revenue by end use
North America accounts for the largest industry share at present and is likely to hold its top position over the forecast period. The key factors driving the growth of North American market comprise of favorable reimbursement structure, especially in the U.S., availability of R&D investments, and increasing adoption of neurovascular devices by neurosurgeons due to the technological sophistication. In addition, the Asia Pacific region will exhibit the highest growth. The major revenue contributor in this region is Japan, accounting for nearly 43% of the market share, and it will retain its top position during the forecast period. The growth can be attributed to technological advancements in the region.
Global Aneurysm Coiling & Embolization Devices Market: Product Type
- Embolic Coils
- Flow Diversion Device
- Liquid Embolic Agents
Global Aneurysm Coiling & Embolization Devices Market: End Users/Application Analysis
- Hospitals
- Ambulatory Surgical Units
- Clinics
Global Aneurysm Coiling & Embolization Devices Market: End Users/Application Analysis
- B.Braun
- Stryker Corp.
- Medtronic Plc
- Cook Group Inc.
- Johnson and Johnson Inc.
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- BALT Group
- Penumbra Inc
- Terumo Corp
Surgical & Interventional Devices Landscape
Report Coverage
| Parameter | Details |
|---|---|
| Base Year | 2025 |
| Historical Data | 2020 – 2025 |
| Forecast Period | 2026 – 2032 |
| Base Year Value | USD 2.19 Billion |
| Forecast Value | USD 4.81 Billion |
| CAGR | 9.1% |
| Regional Scope | North America · Europe · Asia-Pacific · Latin America · MEA · RoW |
Frequently Asked Questions
Aneurysm Coiling & Embolization Devices Market was valued at USD 2.19 Billion in 2025 and is estimated to reach USD 4.81 Billion by 2032.
Aneurysm Coiling & Embolization Devices Market is projected to grow at a CAGR of 9.1% during 2025–2032.
North America accounts for the largest industry share in Aneurysm Coiling & Embolization Devices Market.
Some of the top companies included in the research report are Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic, Penumbra, Inc., Stryker, Terumo Corp.
1. Rising global prevalence of cerebral aneurysms and cerebrovascular disorders, amplified by ageing populations and hypertension, is expanding the treated patient pool. 2. Strong clinical shift from open surgical clipping toward minimally invasive endovascular coiling, driven by shorter recovery times and favourable outcome data. 3. Continuous product innovation - bioactive and hydrogel coils, flow diverters, intrasaccular devices - plus improved neuroimaging and incidental detection rates are widening treatment eligibility.
Yes. The report includes a dedicated section on geopolitical risk factors and their impact on supply chains, pricing, and regional demand dynamics.